| |
<<I find it amazing that
after what happened in January that anyone holds (or even discusses)
this stock at all.>>
Jay,
We kept the thread alive just for you :-)
Talk about faith in this company, I had plenty of opportunity to sell, based on the SB report (see post 31). In fact, SB's tone was very definite that the outcome wouldn't be good at all. From that, we all can tell there might be leaks from the companies (REGN and/or AMGN). I actually wanted to get out before their annoucement of the data, but I didn't know when that day would be; I also considered the worst outcome from the a failure would probably wouldn't be too bad (I expected -6 to 8 bucks at most and I wouldn't lose too much). Because I still had (and have) hope on BDNF from reading different journals, I thought it was a good gamble. (I guess many people believed that as well, since in anticipation of the news release, the price shot up a couple points before running south on the same day) I lost on that, the market reacted very negatively when the announcement came, much worse than I expected.
I believe in neurotrophic factors, although I don't think subcutaneous injection was a good idea (Actually, I did injection of nt-3 in rats too, a different experiment of course, but didn't work for our purpose). Injection for this kind of experiment is kind of unpredictable. I have more confidence in the intrathecal infusion technique. Even better method is using the encapsulated cell technology developed by CTII. In fact, Genentech is doing exactly that with CTII. I received CTII's Annual yesterday, and am reading it. I would post something on that thread when I am done.
Chuck |
|
